The Journal of Endocrinology, Metabolism and Diabetes of South Africa (JEMDSA) is the official journal of SEMDSA (Society for Endocrinology, Metabolism and Diabetes of SA), DESSA (Diabetes Education Society of SA), NOFSA (National Osteoporosis Foundation of SA), SASOM (SA Society of Obesity and Metabolism), LASSA (Lipid and Atherosclerosis Society of SA) and PAEDS-SA (The Paediatric and Adolescent Endocrine and Diabetes Society of SA).

Through stringent peer review, the journal also aims to make a regional contribution to the international knowledge base of endocrinology, metabolism and diabetes and hopes to also offer other African countries the opportunity to make a world-class African contribution.

Readership comprises of the members of the various societies, namely general physicians, endocrinologists, diabetologists, diabetes nurse educators, lipidologists, beriatricians, paediatricians, gynaecologists (specialising in osteoporosis and infertility) and general practitioners with a special interest in endocrinology, metabolism and diabetes.

New review of clinical studies shows that antidepressants are effective, but must be given a chance to work

New review of clinical studies shows that antidepressants are effective, but must be given a chance to work Depression affects millions of people worldwide.1 ref 1A It can be severely disabling, impacting general health and wellbeing, and performance at work and...

The Science is in the Sample – provided it is Representative

Current sampling practice is a result of the combination of statistics with scientific knowledge about the product/material being sampled.  Such knowledge is acquired through experimentation and the use of various sampling techniques until reproducible results, from representative samples, can be obtained. 

NEW LEADERSHIP AT THE HELM OF GENERICS AND BIOSIMILAR MEDICINES ASSOCIATION

Generic and Biosimilar Medicines of Southern Africa (GBMSA), formerly known as the National Association of Pharmaceutical Manufacturers (NAPM), has appointed Erik Roos, CEO of Pharma Dynamics as Vice Chairperson to support the existing Chairperson, Lorraine Keyser, CEO of Dr Reddy’s, as of June 2018.

One year on – Novartis, DST and SAMRC MoU builds scientific capability in South Africa

One year after the signing of a Memorandum of Understanding (MoU) between Novartis, the South African Department of Science and Technology (DST) and South African Medical Research Council (SAMRC), Novartis reports that the collaboration is revealing significant latent potential for scientific discovery in South Africa.

The SpineCor Scoliosis Brace – A first of its kind in South Africa

MER Healthcare Consulting has introduced the new Scoliosis SpineCor Brace to the South African market. SpineCor is 3 dimensional dynamic brace used to help prevent progression of a curve in Idiopathic Scoliosis for adolescents and degenerative painful scoliosis in adults.

JEMDSA (July 2016 – June 2017) | 1 782